Patients who presented tumours that were positive for both p53 and hnRNP K expression had a poorer survival outcome compared with other combinations (p53+/hnRNP K-, p53−/hnRNP K+ and p53−/hnRNP K−). The gene discussed is HNRNPK; the disease is neoplasm.